Presentation ACC 2020

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L. Bhatt

REGISTER for free or LOG IN to view this content

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
Clinical Cardiology
Prevention
Clinical Pharma
Lipids
Coronary
CAD Pharma
Presentation
ACC 2020
Icosapent ethyl
EPA
Vascepa
Amarin

Up Next

More slides +

We Recommend